We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Dual Testing Recommended for Diabetic Children

By LabMedica International staff writers
Posted on 17 May 2011
The hemoglobin A1C (HbA1C) blood test should be used in conjunction with the oral glucose tolerance test for screening overweight children for diabetes. More...


Although the glycosalated HbA1C blood test is easier on the patient, as it does not require fasting, it may not be sensitive to catch overweight children who are at a high risk of developing type 2 diabetes.

Scientists at the Children's Mercy Hospital (Kansas City, MO, USA) evaluated the charts of 629 overweight and adolescent patients who had both the HbA1c and an oral glucose test. They found that 40% of type 2 diabetes patients and 67% of high-risk patients identified through the oral glucose tolerance test would have shown a normal glycemic status if only the hemoglobin A1C test were used to diagnose them. Nearly nine out of ten patients had normal blood glucose levels according to their hemoglobin A1C results.

The study found that the recommended blood test may not be enough to detect type 2 diabetes in overweight children, missing more than two-thirds of children at high-risk for the condition. The investigators found that performing two tests, both the recommended hemoglobin A1C test and an oral glucose tolerance test, could dramatically reduce the risk of delayed diagnosis in overweight children.

Wayne Moore, MD, PhD, chief and medical director of the endocrine/diabetes section at Children's Mercy Hospital, said, "Lifestyle changes and early treatment can help delay disease progression of diabetes. It is important that patients are diagnosed as early as possible for the best outcomes." The findings were presented at the Pediatric Academic Societies Annual Meeting, held from April 30 – May 3, 2011, in Denver (CO, USA).

Related Links:
Children's Mercy Hospital





Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Immunofluorescence Analyzer
IFA System
New
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.